Influence of Psychiatric Diagnoses on Interferon-α Treatment for Chronic Hepatitis C in a Veteran Population

Ho, Samuel B.; Huy Nguyen; Tetrick, Lori L.; Opitz, Greg A.; Basara, Michael L.; Dieperink, Eric
January 2001
American Journal of Gastroenterology;Jan2001, Vol. 96 Issue 1, p157
Academic Journal
OBJECTIVE: The prevalence of psychiatric problems and substance abuse is high in the veteran population with hepatitis C. The purpose of this study was to retrospectively analyze the effect of preexisting psychiatric conditions in veteran patients undergoing treatment with interferon α-2b (IFN-α) with respect to adverse events, compliance, and treatment response. METHODS: Thirty-three veterans with chronic hepatitis C were treated with IFN-α (5 million units three times weekly) for 6 months, followed by a tapering dose for an additional 6 months. All patients fulfilled standard criteria for treatment eligibility. Psychiatric diagnoses, adverse events, and virological and biochemical responses to therapy were determined. RESULTS: Nineteen of 33 (58%) patients with hepatitis C had documented psychiatric conditions before starting IFN-α therapy. Of the patients with preexisting psychiatric diagnoses, 13/19 (68%) developed major adverse events requiring intervention or discontinuation of therapy. In contrast, 4/14 (29%) patients without psychiatric diagnoses developed major adverse events (p = 0.024) In the psychiatric group, 6/19 (32%) developed major neuropsychiatric side effects compared with 2/14 patients (14%) in the non-psychiatric group (p = 0.25). Patients with and without psychiatric diagnoses had equivalent biochemical and virological responses to therapy. Overall, only 2/33 (6%) patients had a sustained virological response. CONCLUSIONS: Veterans with chronic hepatitis C and psychiatric diagnoses experienced a significantly greater number of major adverse events during treatment with IFN-α. Veteran patients with hepatitis C should be carefully screened for psychiatric conditions and may require more intensive monitoring during IFN-α therapy.


Related Articles

  • Treating Chronic Hepatitis C Patients With Psychiatric Disorders: An Uphill Battle. Cheung, Ramsey; Ahmed, Aijaz // American Journal of Gastroenterology;Jan2001, Vol. 96 Issue 1, p3 

    Focuses on hepatitis C virus (HCV) infection. Side effects of taking interferon for the treatment of HCV; Prevalence of HCV infection; Discussion on the neuropsychiatric side effects of interferon therapy in chronic hepatitis C veterans.

  • Rate and predictors of treatment prescription for hepatitis C. Butt, Adeel A.; Justice, Amy C.; Skanderson, Melissa; Rigsby, Michael O.; Good, Chester B.; Kent Kwoh, C. // Gut;Mar2007, Vol. 56 Issue 3, p385 

    Background: The true treatment rate for hepatitis C virus (HCV) in veterans is unknown. Aim: To determine the treatment prescription rates and predictors of treatment prescription for HCV in a large national population. Methods: The Department of Veterans Affairs National Patient Care Database...

  • Prevalence of Hepatitis C virus infection in a sample of homeless veterans. Desai, Rani A.; Rosenheck, Robert A.; Agnello, Vincent // Social Psychiatry & Psychiatric Epidemiology;Jul2003, Vol. 38 Issue 7, p396 

    Objective: This study measures the prevalence of Hepatitis C Virus (HCV) infection in a sample of homeless veterans treated in a Domiciliary Care for Homeless Veterans (DCHV) program in Massachusetts. We also examine risk factors and correlates for HCV infection, including substance abuse and...

  • The Intertwining of Medicine and Psychiatry: Here Comes HCV. Fawcett, Jan // Psychiatric Annals;Jun2003, Vol. 33 Issue 6, p353 

    The article introduces a series of studies on psychiatric issues in hepatitis C patients and on the efficacy of interferon-alpha as treatment.

  • Singin' the Blues: The Downside of Hepatitis C Virus Treatment. Bini, Edmund J. // American Journal of Gastroenterology;Nov2007, Vol. 102 Issue 11, p2434 

    Interferon-based therapies are associated with various neuropsychiatric side effects, and poorly controlled psychiatric disease is an absolute contraindication to interferon and ribavirin therapy. However, treatment of HCV infection in patients with stable psychiatric disease is controversial....

  • A pain in the neck.  // Gut;Nov2012, Vol. 61 Issue 11, p1582 

    A quiz concerning with the medical condition of a 47 year old man suffering with Hepatitis C virus infection is presented.

  • Optimum Duration of Treatment for Hepatitis C. Kuritzky, Louis // Internal Medicine Alert;8/29/2007, Vol. 29 Issue 16, p128 

    The article reports on the optimum duration of treatment for hepatitis C.

  • Ask Professor Ossolotch.  // Current Science;8/30/2002, Vol. 88 Issue 1, p14 

    Discusses the prevalence of hepatitis C in the U.S. Symptoms of the disease; Mode of transmission; Treatment of the illness.

  • CORRECTION.  // Crain's Chicago Business;5/19/2014, Vol. 37 Issue 20, p0002 

    A correction to the article about the hepatitis C therapy of AbbVie Inc. in the May 12, 2014 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics